Jennifer L. Guerriero

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

Constantia Pantelidou, Olmo Sonzogni, Mateus de Oliveira Taveira et al. · Cancer Discovery · 2019 · 649 citations · Full text

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Kevin Bi, Meng Xiao He, Ziad Bakouny et al. · Cancer Cell · 2021 · 583 citations · Full text

Immunology, Immune Cell Therapy, Immunotherapy +16

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera et al. · Nature · 2017 · 540 citations · Full text

Breast Oncology, Medicine, Immunology +9

Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma

Oksana Zavidij, Nicholas J. Haradhvala, Tarek H. Mouhieddine et al. · Nature Cancer · 2020 · 341 citations · Full text

Hematological Malignancy, Single Cell Sequencing, Medicine +14

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Anita K. Mehta, Emily Cheney, Christina Hartl et al. · Nature Cancer · 2020 · 239 citations · Full text

Breast Oncology, Medicine, Immunology +8